Amplitude Surgical Announces Its 2022-23 Financial Calendar
25 November 2022 - 4:00AM
Business Wire
Regulatory News:
Amplitude Surgical (ISIN : FR0012789667, Mnémo : AMPLI, PEA-PME
eligible) (Paris:AMPLI), (“Amplitude” or the
“Group”), French leader on the global surgical technology
market for lower-limb orthopedics, announces its 2022-23 financial
calendar.
Events
Dates *
2022-23 Q1 Sales
Thursday, November 24, 2022
2022-23 H1 Sales
Thursday, February 23, 2023
2022-23 H1 Results
Wednesday, March 22, 2023
2022-23 Q3 Sales
Thursday, April 20, 2023
2022-23 Full-Year Sales
Thursday, July 20, 2023
2022-23 Full-Year Results
Wednesday, October 18, 2023
2023-24 Q1 Sales
Thursday, November 23, 2023
* Subject to modification. Press releases are published after
market closes.
Next press release: H1 2022-23 sales, on Thursday
February 23, 2023, after market.
About Amplitude Surgical
Founded in 1997 in Valence, France, Amplitude Surgical is a
leading French player on the global surgical technology market for
lower-limb orthopedics. Amplitude Surgical develops and markets
high-end products for orthopedic surgery covering the main
disorders affecting the hip, knee and extremities, and notably foot
and ankle surgery. Amplitude Surgical develops, in close
collaboration with surgeons, numerous high value-added innovations
in order to best meet the needs of patients, surgeons and
healthcare facilities. A leading player in France, Amplitude
Surgical is developing abroad through its subsidiaries and a
network of exclusive distributors and agents distributing its
products in more than 30 countries. Amplitude Surgical operates on
the lower-limb market through the intermediary of its Novastep
subsidiaries in France and the United States. At June 30, 2022,
Amplitude Surgical had a workforce of 460 employees and recorded
sales of nearly 104.8 million euros (including foot and ankle
activity and before application of IFRS 5).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221124005213/en/
Amplitude Surgical Dimitri Borchtch CFO
finances@amplitude-surgical.com +33 (0)4 75 41 87 41
NewCap Investor Relations Thomas Grojean
amplitude@newcap.eu +33 (0)1 44 71 94 94
NewCap Media Relations Nicolas Merigeau
amplitude@newcap.eu +33 (0)1 44 71 94 98
Amplitude Surgical (EU:AMPLI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amplitude Surgical (EU:AMPLI)
Historical Stock Chart
From Apr 2023 to Apr 2024